查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771458

過敏診斷市場規模、佔有率、趨勢分析報告：按產品/服務、過敏原、測試類型、最終用途、地區、細分市場預測，2025-2030 年

Allergy Diagnostics Market Size, Share & Trends Analysis Report By Products And Services, By Allergen, By Test Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10個工作天內

價格

過敏診斷市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球過敏診斷市場規模預計到2030年將達到116.3億美元，2025-2030年期間的複合年成長率為10.39%。

過敏仍然是美國乃至全球的重大公共衛生問題，影響著兒童和成人。根據美國疾病管制與預防中心 (CDC) 2023 年的全國健康訪問調查 (NHIS)，約有 25.7% 的美國成人和 18.9% 的兒童報告被診斷患有季節性過敏、濕疹或食物過敏。這些數據凸顯了過敏性疾病盛行率的不斷上升，反映出迫切需要更好的診斷工具和早期檢測策略，以減少併發症並提高生活品質。

此外，根據過敏和氣喘網路的統計，每年有超過5000萬美國患有過敏症，過敏是美國第六大慢性病原因。光是食物過敏就影響了大約560萬兒童（約每13人中就有1人）和大約2600萬成年人，這進一步凸顯了對準確和易於獲取的診斷解決方案的需求。此外，通常由過敏原引發的氣喘影響超過2500萬美國，其中包括420萬名兒童。這些數字顯示過敏性疾病的醫療負擔日益加重，並支持對先進診斷和早期療育進行投資的必要性。

美國人口結構變化

  • 成人：
    • 與非西班牙裔黑人（24%）、西班牙裔（18.8%）和非西班牙裔亞裔（17%）成年人相比，非西班牙裔白人成年人更容易患有季節性過敏症（28.4%）。
    • 女性濕疹的盛行率（8.9%）高於男性（5.7%）。
    • 非西班牙裔黑人成年人的食物過敏盛行率（8.5%）高於西班牙裔（4.4%）、非西班牙裔白人（6.2%）和非西班牙裔亞裔（4.5%）成年人。
  • 孩子：
    • 男孩（20%）比女孩（17.7%）更容易有季節性過敏。
    • 6～11歲兒童濕疹盛行率最高（12.1%），其次為0～5歲兒童（10.4%）及12～17歲兒童（9.8%）。
    • 與西班牙裔兒童（5%）和非西班牙裔白人兒童（5.3%）相比，非西班牙裔黑人兒童更容易出現食物過敏（7.6%）。

過敏性疾病的經濟影響也十分顯著，每年因急診、住院和生產力損失，美國醫療保健系統損失數十億美元。不斷上升的過敏盛行率、醫療成本以及嚴重過敏反應的風險，共同催生了市場對創新過敏診斷試劑盒的迫切需求，這些試劑盒應具備準確性、快速性和可及性，適用於從基層醫療到專科診所，甚至家用檢測套組等各種環境。

全球過敏診斷市場的主要企業包括賽默飛世爾科技公司、HYCOR Biomedical、EUROIMMUN Medizinische Labordiagnostika AG（PerkinElmer，Inc.）、Omega Diagnostics Group PLC、Lincoln Diagnostics，Inc.、AESKU.GROUP GmbH、Minabharm Group.R. AG、bioMerieux 和西門子醫療股份有限公司。

這些公司積極參與策略性舉措，例如新產品發布、監管核准和技術進步，以加強其在全球市場的地位並擴展其過敏檢測產品組合。例如，賽默飛世爾科技於2022年5月推出了高通量體外過敏和自體免疫檢測的Phadia 2500+系列，以擴展其在美國的過敏診斷產品組合，並提高實驗室效率和精準診斷。此次產品發布滿足了對全面過敏檢測組和分子水平檢測日益成長的需求，以應對美國和歐洲等主要市場日益增多的食物過敏和呼吸道過敏病例，尤其是在老年人和兒童群體中。

過敏診斷市場報告重點

  • 根據產品和服務，耗材在 2024 年佔據了最大的收入佔有率，為 63.14%。這種主導地位歸因於需要頻繁補充試劑、檢測套組和其他對過敏測試程序至關重要的消耗品，以及全球過敏診斷測試數量的不斷增加。
  • 按過敏原分類，吸入式過敏將佔據市場主導地位，到 2024 年將佔據 49.72% 的最大收益佔有率。這主要是由於花粉、塵蟎、黴菌孢子、動物皮屑等空氣傳播的過敏原引起的呼吸道過敏盛行率很高，需要進行廣泛和常規的診斷測試。
  • 根據測試類型，試管內測試在 2024 年佔據市場最高收益佔有率。試管內測試之所以受到青睞，是因為它們安全性高、可重複性強，並且能夠提供可同時檢測多種過敏原的綜合面板，這使得它們在臨床和研究環境中都受到青睞。
  • 根據最終用途，醫院和診所將在 2024 年佔據最高的收入佔有率，達到 37.23%，這是由於過敏診斷擴大融入醫院的門診護理、轉診至專科過敏護理的數量不斷增加以及從臨床角度對準確的實驗室測試的需求。
  • 從地區來看，北美將引領全球市場，佔 2024 年營收的 36.53%。這種主導地位可以歸因於該地區完善的醫療保健基礎設施、對過敏相關健康風險的高度認知、強力的報銷政策以及提供先進診斷解決方案的主要行業參與者的存在。
  • 預計亞太地區將成長最快，2024 年至 2030 年的複合年成長率為 11.43%。推動這一成長的因素包括都市化加快、環境污染加劇、飲食習慣改變導致新的食物過敏以及醫療保健服務的普及，尤其是在中國和印度等新興經濟體。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 過敏診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 過敏診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章過敏診斷市場：產品和服務估計和趨勢分析

  • 2024 年和 2030 年按產品和服務分類的市場佔有率
  • 細分儀表板
  • 全球過敏診斷市場（按產品/服務）展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 裝置
    • 耗材
    • 服務

第5章過敏診斷市場：過敏原估計與趨勢分析

  • 2024 年及 2030 年過敏原市場佔有率
  • 細分儀表板
  • 全球過敏診斷市場（按過敏原）
  • 2018年至2030年市場規模、預測及趨勢分析
    • 食物
    • 吸入
    • 其他

第6章過敏診斷市場：測試類型估計和趨勢分析

  • 2024 年和 2030 年各測試類型的市場佔有率
  • 細分儀表板
  • 全球過敏診斷市場展望（按測試類型）
  • 2018年至2030年市場規模、預測及趨勢分析
    • 體內測試

第7章過敏診斷市場：最終用途估計與趨勢分析

  • 2024 年和 2030 年按最終用途分類的市場佔有率
  • 細分儀表板
  • 全球過敏診斷市場展望（按最終用途）
  • 2018年至2030年市場規模、預測及趨勢分析
    • 研究所
    • 醫院和診所
    • 診斷實驗室
    • 其他

第8章過敏診斷市場：區域估計和趨勢分析

  • 2024 年及 2030 年各地區市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
    • 北美：SWOT分析
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲：SWOT分析
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 亞太地區：SWOT分析
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 拉丁美洲：SWOT分析
    • 巴西
    • 阿根廷
  • 中東和非洲
    • MEA：SWOT分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Key company market share analysis, 2024
    • Thermo Fisher Scientific, Inc.
    • HYCOR Biomedical
    • EUROIMMUN Medizinische Labordiagnostika AG（PerkinElmer, Inc.）
    • Omega Diagnostics Group PLC
    • Lincoln Diagnostics, Inc.
    • AESKU.GROUP GmbH
    • Minaris Medical America, Inc.
    • HOB Biotech Group Corp., Ltd.
    • DASIT Group SPA
    • R-Biopharm AG
    • bioMerieux
    • Siemens Healthcare GmbH
Product Code: GVR-4-68040-600-0

Allergy Diagnostics Market Growth & Trends:

The global allergy diagnostics market size is expected to reach USD 11.63 billion by 2030, registering a CAGR of 10.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. Allergies continue to be a significant public health concern in the U.S. and worldwide, affecting both children and adults across all demographics. According to the CDC's 2023 National Health Interview Survey (NHIS), approximately 25.7% of adults and 18.9% of children in the U.S. reported being diagnosed with seasonal allergies, eczema, or food allergies. This data highlights the growing prevalence of allergic conditions, reflecting an urgent need for better diagnostic tools and early detection strategies to reduce complications and improve quality of life.

Additionally, statistics from the Allergy & Asthma Network reveal that over 50 million Americans suffer from allergies each year, making them the sixth leading cause of chronic illness in the U.S. Food allergies alone affect an estimated 5.6 million children (around one in 13), and about 26 million adults further underlining the need for precise and accessible diagnostic solutions. Moreover, asthma, which is often triggered by allergens, affects more than 25 million Americans, including 4.2 million children. These figures point to the growing healthcare burden of allergic diseases and support the case for investments in advanced diagnostics and early intervention.

U.S. Demographic Variations:

  • Adults:
    • Non-Hispanic White adults were more likely to have seasonal allergies (28.4%) compared to Non-Hispanic Black (24%), Hispanic (18.8%), and Non-Hispanic Asian (17%) adults.
    • Eczema prevalence was higher among women (8.9%) than men (5.7%).
    • Non-Hispanic Black adults had a higher prevalence of food allergies (8.5%) compared to Hispanic (4.4%), Non-Hispanic White (6.2%), and Non-Hispanic Asian (4.5%) adults.
  • Children:
    • Boys (20%) were more likely to have seasonal allergies than girls (17.7%).
    • Children aged 6-11 years had the highest prevalence of eczema (12.1%), followed by those aged 0-5 years (10.4%), and 12-17 years (9.8%).
    • Non-Hispanic Black children were more likely to have food allergies (7.6%) compared to Hispanic (5%) and Non-Hispanic White (5.3%) children

The economic impact of allergic diseases is also substantial, costing the U.S. healthcare system billions annually due to emergency visits, hospitalizations, and lost productivity. The combination of rising prevalence, healthcare costs, and the risk of severe allergic reactions has created a compelling market demand for innovative allergy diagnostics that can offer accuracy, speed, and accessibility across various settings, from primary care to specialty clinics and even at-home testing kits.

Some of the key players in the global allergy diagnostics market include Thermo Fisher Scientific, Inc., HYCOR Biomedical, EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.), Omega Diagnostics Group PLC, Lincoln Diagnostics, Inc., AESKU.GROUP GmbH, Minaris Medical America, Inc., HOB Biotech Group Corp., Ltd., DASIT Group SPA, R-Biopharm AG, bioMerieux, and Siemens Healthcare GmbH.

These companies are actively engaged in strategic initiatives such as new product launches, regulatory approvals, and technology advancements to strengthen their global market presence and expand their allergy testing portfolios. For instance, in May 2022, Thermo Fisher Scientific expanded its allergy diagnostics offering in the U.S. by launching its Phadia 2500+ series for high-throughput in vitro allergy and autoimmune testing, enhancing lab efficiency and precision diagnostics. This launch supports the growing demand for comprehensive allergy panels and molecular-level testing, addressing increasing cases of food and respiratory allergies, particularly in aging and pediatric populations across key markets like the U.S. and Europe.

Allergy Diagnostics Market Report Highlights:

  • Based on products and services, consumables accounted for the largest revenue share of 63.14% in 2024. This dominance is attributed to the frequent need for replenishment of reagents, test kits, and other consumable materials essential for allergy testing procedures, as well as the increasing volume of allergy diagnostic tests conducted globally.
  • Based on allergen, inhaled dominated the market and accounted for the largest revenue share of 49.72% in 2024. This is primarily due to the high prevalence of respiratory allergies caused by airborne allergens such as pollen, dust mites, mold spores, and animal dander, which necessitate widespread and routine diagnostic testing.
  • Based on test type, the in vitro test led the market with the highest revenue share in 2024. The preference for in vitro tests is driven by their safety, reproducibility, and ability to provide comprehensive panels that can detect multiple allergens simultaneously, making them a preferred choice in both clinical and research settings.
  • Based on end use, hospitals and clinics held the highest revenue share of 37.23% in 2024. This is due to the growing integration of allergy diagnostics into hospital outpatient services, increasing referrals for specialized allergy care, and the demand for accurate, laboratory-based testing within clinical settings.
  • Based on region, North America led the global market, accounting for 36.53% of the revenue in 2024. This dominance is attributed to the region's well-established healthcare infrastructure, high awareness of allergy-related health risks, strong reimbursement policies, and the presence of key industry players offering advanced diagnostic solutions.
  • The Asia Pacific region is projected to witness the fastest growth, with a CAGR of 11.43% from 2024 to 2030. Factors driving this growth include rising urbanization, increasing environmental pollution, changing dietary habits leading to new food allergies, and expanding access to healthcare services, particularly in emerging economies such as China and India.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Products and Services
    • 1.2.2. Allergen
    • 1.2.3. Test Type
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Products and Services Outlook
    • 2.2.2. Test Type Outlook
    • 2.2.3. Allergen Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Allergy Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing Allergy Prevalence
      • 3.2.1.2. Advancements in Diagnostic Techniques
      • 3.2.1.3. Significant investments from government bodies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited accessibility to advanced technologies
      • 3.2.2.2. High Manufacturing Costs
  • 3.3. Allergy Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Allergy Diagnostics Market: Products and Services Estimates & Trend Analysis

  • 4.1. Products and Services Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Allergy Diagnostics Market by Products and Services Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Instruments
      • 4.4.1.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Consumables
      • 4.4.2.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Services
      • 4.4.3.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Allergy Diagnostics Market: Allergen Estimates & Trend Analysis

  • 5.1. Allergen Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Allergy Diagnostics Market by Allergen Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Food
      • 5.4.1.1. Food market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.2. Dairy Products
        • 5.4.1.2.1. Dairy products market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.3. Poultry Product
        • 5.4.1.3.1. Poultry products market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.4. Tree Nuts
        • 5.4.1.4.1. Tree nuts market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.5. Peanuts
        • 5.4.1.5.1. Peanuts market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.6. Shellfish
        • 5.4.1.6.1. Shellfish market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.7. Wheat
        • 5.4.1.7.1. Wheat market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.8. Soys
        • 5.4.1.8.1. Soys market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.4.1.9. Other Food Allergens
        • 5.4.1.9.1. Other food allergens market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Inhaled
      • 5.4.2.1. Inhaled market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Other Allergens
      • 5.4.3.1. Other Allergens market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Allergy Diagnostics Market: Test Type Estimates & Trend Analysis

  • 6.1. Test Type Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Allergy Diagnostics Market by Test Type Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. In Vivo Test
      • 6.4.1.1. In Vivo Test market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.2. Skin Prick Test
        • 6.4.1.2.1. Skin Prick Test market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.3. Intradermal Test
        • 6.4.1.3.1. Intradermal Test market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.4. Patch Test
        • 6.4.1.4.1. Patch Test market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.5. In vitro Test
      • 6.4.1.6. In Vitro market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Allergy Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Allergy Diagnostics Market by End Use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Research Institutions
      • 7.4.1.1. Research Institutions market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Hospitals & Clinics
      • 7.4.2.1. Hospitals & Clinics market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Diagnostic Laboratories
      • 7.4.3.1. Diagnostic Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Allergy Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts, Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. North America: SWOT Analysis
    • 8.5.2. U.S.
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. Europe: SWOT Analysis
    • 8.6.2. UK
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. Germany
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. France
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Italy
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Spain
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Norway
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Sweden
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.9. Denmark
      • 8.6.9.1. Key country dynamics
      • 8.6.9.2. Regulatory framework
      • 8.6.9.3. Competitive scenario
      • 8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Asia Pacific: SWOT Analysis
    • 8.7.2. Japan
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. China
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. India
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. Australia
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. South Korea
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.7. Thailand
      • 8.7.7.1. Key country dynamics
      • 8.7.7.2. Regulatory framework
      • 8.7.7.3. Competitive scenario
      • 8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Latin America: SWOT Analysis
    • 8.8.2. Brazil
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. MEA: SWOT Analysis
    • 8.9.2. South Africa
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.5. Kuwait
      • 8.9.5.1. Key country dynamics
      • 8.9.5.2. Regulatory framework
      • 8.9.5.3. Competitive scenario
      • 8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Thermo Fisher Scientific, Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Services benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. HYCOR Biomedical
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Services benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.)
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Services benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Omega Diagnostics Group PLC
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Services benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Lincoln Diagnostics, Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Services benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. AESKU.GROUP GmbH
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Services benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Minaris Medical America, Inc.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Services benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. HOB Biotech Group Corp., Ltd.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Services benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. DASIT Group SPA
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Services benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. R-Biopharm AG
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Services benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. bioMerieux
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Services benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. Siemens Healthcare GmbH
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Services benchmarking
      • 9.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 List of Secondary Sources
  • Table 3 Regulatory Framework
  • Table 4 Global Allergy Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 6 Global Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 7 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 8 Global Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 9 North America Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 11 North America Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 12 North America Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 North America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 14 North America Allergy Diagnostics Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 U.S. Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 16 U.S. Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 17 U.S Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 U.S. Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 19 Canada Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 20 Canada Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 21 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 22 Canada Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 23 Mexico Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 24 Mexico Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 25 Mexico Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 Mexico Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 27 Europe Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 28 Europe Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 29 Europe Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 30 Europe Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 31 Europe Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 32 UK Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 33 UK Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 34 UK Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 35 UK Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 36 Germany Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 37 Germany Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 38 Germany Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 39 Germany America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 40 France Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 41 France Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 42 France Rapid Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 43 France Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 44 Spain Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 45 Spain Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 46 Spain Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 48 Italy Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 49 Italy Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 50 Italy Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 51 Italy Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 56 Asia-Pacific Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 57 China Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 58 China Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 59 China Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 60 China Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 61 Japan Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 62 Japan Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 63 Japan Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 65 India Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 66 India Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 67 India Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 68 India Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 69 South Korea Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 70 South Korea Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 71 South Korea Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 72 South Korea Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 73 Australia Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 74 Australia Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 75 Australia Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 76 Australia Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 77 Latin America Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 78 Latin America Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 79 Latin America Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 80 Latin America Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 81 Latin America Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 82 Brazil Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 83 Brazil Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 84 Brazil Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 85 Brazil Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 86 Argentina Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 87 Argentina Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 88 Argentina Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 89 Argentina Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 90 MEA Allergy Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 91 MEA Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 92 MEA Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 93 Global Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 94 MEA Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 95 South Africa Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 96 South Africa Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 97 South Africa Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 98 South Africa Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 99 UAE Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 100 UAE Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 101 UAE Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 102 UAE Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)
  • Table 107 Kuwait Allergy Diagnostics Market, By Products and Services, 2018 - 2030 (USD Million)
  • Table 108 Kuwait Allergy Diagnostics Market, By Allergen, 2018 - 2030 (USD Million)
  • Table 109 Kuwait Allergy Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 110 Kuwait Allergy Diagnostics Market, By End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Allergy Diagnostics: market outlook
  • Fig. 14 Allergy Diagnostics competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Allergy Diagnostics driver impact
  • Fig. 20 Allergy Diagnostics restraint impact
  • Fig. 21 Allergy Diagnostics strategic initiatives analysis
  • Fig. 22 Allergy Diagnostics: Products and Services movement analysis
  • Fig. 23 Allergy Diagnostics: Products and Services outlook and key takeaways
  • Fig. 24 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Allergy Diagnostics: Allergen movement analysis
  • Fig. 28 Allergy Diagnostics: Allergen outlook and key takeaways
  • Fig. 29 Food market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Dairy Products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Poultry Product market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Tree Nuts market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Peanuts market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Shellfish market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Wheat market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Soys market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Other Food Allergens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Inhaled market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Other Allergens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Allergy Diagnostics: Test Type movement analysis
  • Fig. 41 Allergy Diagnostics: Test Type outlook and key takeaways
  • Fig. 42 In Vivo Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Skin Prick Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Intradermal Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Patch Test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 In Vitro market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Allergy Diagnostics: End use movement analysis
  • Fig. 49 Allergy Diagnostics: End use outlook and key takeaways
  • Fig. 50 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Diagnostics Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Research Institutions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Global allergy diagnostics market: Regional movement analysis
  • Fig. 55 Global allergy diagnostics market: Regional outlook and key takeaways
  • Fig. 56 Global allergy diagnostics market shares and leading players
  • Fig. 57 North America
  • Fig. 58 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 U.S.
  • Fig. 60 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Canada
  • Fig. 62 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico
  • Fig. 64 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Europe
  • Fig. 66 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 UK
  • Fig. 68 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Germany
  • Fig. 70 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 France
  • Fig. 72 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Italy
  • Fig. 74 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Spain
  • Fig. 76 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Denmark
  • Fig. 78 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Sweden
  • Fig. 80 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Norway
  • Fig. 82 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Asia Pacific
  • Fig. 84 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 China
  • Fig. 86 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Japan
  • Fig. 88 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 India
  • Fig. 90 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand
  • Fig. 92 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 South Korea
  • Fig. 94 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Australia
  • Fig. 96 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America
  • Fig. 98 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil
  • Fig. 100 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina
  • Fig. 102 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 South Africa
  • Fig. 106 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Saudi Arabia
  • Fig. 108 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Market share of key market players - Allergy Diagnostics